These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3094573)

  • 21. Allo-immunization during pregnancy. Clinical results from 1983 to 1989 in a Scandinavian university hospital.
    Belfrage P; Thomassen P; Floberg J; Akerblom O; Broberger U
    Acta Obstet Gynecol Scand; 1992 May; 71(4):273-7. PubMed ID: 1322620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of Rh haemolytic disease.
    Tovey LA; Murray J; Stevenson BJ; Taverner JM
    Br Med J; 1978 Jul; 2(6130):106-8. PubMed ID: 96908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhesus immunization: new perspectives in maternal-fetal medicine.
    Stangenberg M; Selbing A; Lingman G; Westgren M
    Obstet Gynecol Surv; 1991 Apr; 46(4):189-95. PubMed ID: 1902926
    [No Abstract]   [Full Text] [Related]  

  • 25. Antenatal suppression of Rh alloimmunization.
    Bowman JM
    Clin Obstet Gynecol; 1991 Jun; 34(2):296-303. PubMed ID: 1651184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 27. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 29. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women.
    Kornstad L
    NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of rhesus immunization in Australia. The first seven years.
    Davey MG
    Med J Aust; 1975 Aug; 2(7):263-7. PubMed ID: 808697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae.
    Tovey LA; Townley A; Stevenson BJ; Taverner J
    Lancet; 1983 Jul; 2(8344):244-6. PubMed ID: 6135077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [15 years of Rh-immunization prevention program].
    Eklund J; Nevanlinna HR
    Katilolehti; 1984; 89(8):284-7. PubMed ID: 6441856
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma exchange in the management of severe rhesus haemolytic disease.
    Halligan A; McGuinness EP
    Ir Med J; 1990 Sep; 83(3):107-8. PubMed ID: 2121660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units.
    Harkness M; Freer Y; Prescott RJ; Warner P
    Transfus Med; 2008 Oct; 18(5):292-5. PubMed ID: 18937736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of anti-D prevention on the incidence of irregular erythrocyte antibodies in pregnant patients].
    Finger H; Drechsler HJ; Wirsing von König CH
    Immun Infekt; 1987 Nov; 15(6):208-15. PubMed ID: 3125103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
    Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
    BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.
    Chandrasekar A; Morris KG; Tubman TR; Tharma S; McClelland WM
    Ulster Med J; 2001 Nov; 70(2):89-94. PubMed ID: 11795772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deaths from rhesus haemolytic disease in England and Wales in 1977: accuracy of records and assessment of anti-D prophylaxis.
    Clarke C; Whitfield AG
    Br Med J; 1979 Jun; 1(6179):1665-9. PubMed ID: 111758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.